Settlement guide

What Could I Get for a Depo-Provera Claim?

Have a Depo-Provera claim? A program may cover some existing cases.

See If You Qualify

Free · No obligation · About 2 minutes

Updated Oct 4, 202616 sources

This may apply to you if

  • Have your shot name and dates ready for a lawyer to review.
  • Have the report that names your meningioma, a tumor in tissue around the brain.
  • If you already have a lawyer, ask whether your claim is eligible for the reported program.

What the public record says

These are cited sources. Their inclusion does not imply that they endorse People’s Justice or reviewed this page.

M. Casey Rodgers · U.S. District Court, Northern District of Florida · United States District Judge

Finding: The August 10, 2026 order describes an agreement for many existing federal claims and separate court procedures for continuing litigation. Ask a lawyer which track applies to you.

Case Management Order No. 14 (opens in a new tab) · Aug 10, 2026 · Checked Oct 3, 2026

Noémie Roland · EPI-PHARE, French National Agency for Medicines and Health Products Safety and French National Health Insurance · First-listed study author

Finding: The 2024 BMJ study found an association between injectable medroxyprogesterone use and meningioma surgery in French health records. A small exposed group and observational design limit what it can show about an individual.

Use of progestogens and the risk of intracranial meningioma: national case-control study (opens in a new tab) · Mar 27, 2024 · Checked Oct 3, 2026

The evidence and its limits

EPI-PHARE · BMJ · 2024

French health-record study of hormone medicines and meningioma surgery

Design:
Case-control
Participants:
108,366 women: 18,061 surgery cases and 90,305 matched controls
Finding:
Injectable medroxyprogesterone acetate use was associated with higher odds of surgery for meningioma; the excess was linked to prolonged use.
Main limitation
Observational French data; only nine exposed cases and eleven exposed controls for this injection. The study does not prove that the shot caused any one person’s tumor or define who qualifies for a claim.

Read the source: French health-record study of hormone medicines and meningioma surgery (opens in a new tab) · Checked Oct 3, 2026

The short answer

Has a Depo-Provera settlement been announced?
Yes. The court reports an agreement for many existing claims. Ask your lawyer whether your claim is in that program. [1]
What do we know about individual amounts?
The court notice does not give a per-person payment grid. Request the terms that apply to your own claim before relying on a number. [1]
What factors determine whether the program covers me?
Program access and the value of an offer are different questions. Ask your lawyer to explain both with your records in view. [1]
What fees or costs could reduce my payment?
Ask for your fee and expense terms in writing. Ask for a clear breakdown of the amount you would keep. [5]

What rules a case out

Not covered by this case

  • A public court notice is not your personal offer or proof of payment.
  • The program registration date is not every person’s filing deadline.
  • A study finding does not decide whether one person’s tumor was caused by the shot.

The process

What happens next

  1. 01

    You answer a few questions

    About two minutes. Nothing is sent until you agree on the last step and press submit.

  2. 02

    A lawyer looks at it

    A lawyer at the firm reads your answers and checks them against the current case criteria.

  3. 03

    The firm decides and gets in touch

    If the firm takes your case, you get the terms in writing to read before you sign. You can always say no.

Couple reading a settlement letter together at the kitchen table
Photo illustration.

Settlement · Announced

A settlement was announced on July 22, 2026.

CMO 14 describes an agreement for many existing federal cases. A signed agreement with a lawyer by June 11, 2026 and program eligibility are required for the administrative track. New claims follow a separate track under the order. Ask a lawyer about your own options.

Announced
July 22, 2026
Registration deadline
November 30, 2026
CMO 14 describes an agreement for many existing federal cases. A signed agreement with a lawyer by June 11, 2026 and program eligibility are required for the administrative track.

Have a Depo-Provera claim? A program may cover some existing cases. Ask your lawyer which track applies and request your own written offer.

Has a Depo-Provera settlement been announced?

Yes. The court reports an agreement for many existing claims. Ask your lawyer whether your claim is in that program.

Judge M. Casey Rodgers describes the agreement in an August 10, 2026 order. It is dated July 22, 2026. The settling companies do not admit fault.

The order also sets procedures for claims that continue in court. A program announcement does not mean every person who used the shot receives an offer.

What do we know about individual amounts?

The court notice does not give a per-person payment grid. Request the terms that apply to your own claim before relying on a number.

This order describes the program and ongoing litigation. It does not let us calculate your payment or give you an award date. Your lawyer should explain any offer and the choices attached to it.

What factors determine whether the program covers me?

The court describes claims for meningiomas inside the skull. Program access and the value of an offer are different questions. Ask your lawyer to explain both with your records in view.

The order limits its administrative filing route to eligible people who signed a lawyer engagement letter by June 11, 2026. That rule does not say everyone outside this route has no claim.

Other parts address new filings and continuing cases. Do not use the administrative cutoff as your own filing deadline. Give counsel your product, treatment, diagnosis and case dates.

What fees or costs could reduce my payment?

Ask for your fee and expense terms in writing. Ask for a clear breakdown of the amount you would keep.

ABA Model Rule 1.5 describes written terms for fees based on the outcome. It addresses fee calculation and case expenses. It is a model rule; your state and signed agreement need checking.

The cited common-benefit order places its specified assessment on the lawyer’s fee portion. That assessment is a separate issue from your own legal fee. Ask about any other deductions, liens or tax questions in your case.

When could a payment arrive?

The public order does not promise a payment date for you. Ask the firm handling your claim what steps remain before any funds can be sent.

The court says it understands program registration closes November 30, 2026. Registration is not the same as a payment date. It is also not a universal lawsuit deadline.

Get the next action and date in writing. If a deadline is unclear, request a personal time-limit review instead of waiting for a payment forecast.

Should I trust an online payment estimate?

Treat a website number as a question to check, not your offer. Ask where the figure came from and whether the terms apply to your claim.

The court order does not supply the individual award grid. Study results also do not measure lawsuit payments. The French study found an association with meningioma surgery, not an amount owed to any reader.

What happens if I ask for a check?

Start by naming the firm that already handles your case, if you have one. Ask it to explain your program status, next deadline and written terms.

If you have no lawyer, gather the records you already hold and ask about claim review. The order recognizes future-filed claims, but acceptance and legal merit still need a personal assessment.

Covered health records generally have an access route under federal rules, with exceptions. Ask the provider how to request your treatment records. Keep copies of requests and replies.

For care questions, contact your treating clinician. The FDA label directs clinicians to stop this medicine if a meningioma is diagnosed; this page does not manage your treatment.

Fees, liens and tax

Lawyer fees and costs

Injury cases are usually on contingency: the firm is paid a share of what you recover, and nothing if you recover nothing. The percentage and how case costs are handled are in the agreement you sign. Ask for both in writing.

Medical liens

If insurance, Medicare or Medicaid paid for your treatment, they can claim part of the award back. Those amounts are worked out before you are paid, and your lawyer can often negotiate them down.

Tax

Compensation for a physical injury is generally not taxable federally. Interest and punitive damages can be. Check with a tax professional.

Find out where you stand.

The review is free and private. Asking for it doesn’t commit you to anything.

Register your interest

Questions about this guide

Should I wait for trial results before filing?

It depends. The public Depo-Provera court source reviewed here addresses procedure or case status. It does not decide an individual person's claim, payment, or deadline. A lawyer can check the current docket and your records.

Source: Case Management Order No. 14, In re Depo-Provera MDL 3140 · as of Oct 7, 2026

How long will the lawsuit take?

On June 15, 2026, Judge M. Casey Rodgers noted an agreement in principle between Pfizer and plaintiffs' lead counsel and vacated upcoming bellwether trial deadlines. Case Management Order No. 14, filed August 10, 2026, describes a settlement program, memorialized in an agreement dated July 22, 2026, that offers many people with existing federal cases a way to resolve their claims. It states no compensation amounts or payment dates, and it sets a separate track for cases filed later. The court understands registration for the program closes November 30, 2026.

What percentage does the lawyer take?

Fee terms are set in your written agreement with the firm. Under ABA Model Rule 1.5, a contingent-fee agreement must be in a writing signed by the client and state how the fee is worked out, including the percentage, the expenses deducted from any recovery and whether they come out before or after the fee is calculated, and any expenses you would owe even if you do not win. The MDL 3140 court also has a separate order about shared legal-work (common benefit) fees; for claims it covers, that assessment comes from the lawyer's fee portion, not by reducing your recovery, and it does not replace your own fee agreement.

Sources

  1. Court order 14: settlement and ongoing casesCourt order 14: settlement and ongoing cases · court
  2. JPML pending cases report, October 1, 2026JPML pending cases report, October 1, 2026 · court
  3. FDA Depo-Provera CI label, December 2025FDA Depo-Provera CI label, December 2025 · regulator
  4. National Cancer Institute: meningiomaNational Cancer Institute: meningioma · regulator
  5. ABA Model Rule 1.5: feesABA Model Rule 1.5: fees
  6. Medical record access: 45 CFR 164.524Medical record access: 45 CFR 164.524 · regulator
  7. SDNY court guide: filing time limitsSDNY court guide: filing time limits · court
  8. Court common-benefit fee order 2Court common-benefit fee order 2 · court
  9. BMJ 2024 original author abstract via PubMedBMJ 2024 original author abstract via PubMed · study
  10. Medroxyprogesterone Acetate and Meningioma: A Global IssueFrontiers in Global Womens Health · 2025 · study
  11. Use of High-Dose Medroxyprogesterone Acetate and Risk of Intracranial MeningiomaThe BMJ · 2024 · study
  12. The Association between Medroxyprogesterone Acetate Exposure and MeningiomaCancers · 2024 · study
  13. Pfizer Reaches Agreement in Principle to Resolve Federal Depo-Provera MDLlaw360.com · Jun 15, 2026 · court
  14. JAMA Network Open Study Reports 4.5x Meningioma Risk with Medroxyprogesteronepubmed.ncbi.nlm.nih.gov · Jul 1, 2026 · study
  15. On June 15, 2026, MDL 3140 (N.D. Fla.) Leadership Counsel announced a settlement with the Pfizer defendants of a majority of the claims in the MDL and New York state court over Depo-Provera meningioma claims (Case Management Order No. 12, filed July 27, 2026). Financial terms NOT disclosed; eligibility and compensation amounts not released; deal pending finalization at the time (Case Management Order No. 14, filed Aug. 10, 2026, later described a settlement agreement dated July 22, 2026 and states no compensation amounts). The JPML reported 5,830 actions pending in MDL 3140 on July 1, 2026 and 6,412 on October 1, 2026.flnd.uscourts.gov · Jun 15, 2026 · court
  16. Settlement in principle announced; docket had grown +1,739 filings (+46%) in the single preceding month — the leading-indicator pattern.jpml.uscourts.gov · Jun 15, 2026 · court

Checked against 14 primary sources by People's Justice editors · Updated

How we make money

People's Justice research team · Updated Oct 4, 2026